GlassScriptPhysician profile
Erin Lewis
NPI 1356955231
$1,689.46
in general payments reported to CMS, 2019-2025
19 companies · $563 in 2025
The $563 reported for 2025 was more than what 75% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $289 · 2022: $126 · 2023: $134 · 2024: $578 · 2025: $563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,185 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,184.78 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $561.43 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $169.92 | 2021-2025 | |
| Janssen Biotech, INC. | $168.75 | 2025 | Tremfya |
| E.R. Squibb & Sons, L.L.C. | $136.06 | 2023-2025 | Sotyktu |
| Leo Pharma INC. | $127.95 | 2021-2025 | Adbry |
| Ucb, INC. | $110.01 | 2021-2025 | Bimzelx |
| Pfizer INC. | $94.18 | 2021-2024 | |
| Sun Pharmaceutical Industries INC. | $66.42 | 2021-2025 | |
| Amgen INC. | $54.23 | 2024-2025 | Otezla, Otezla |
| Fresenius Kabi USA, LLC | $34.55 | 2023-2024 | Idacio |
| Lilly USA, LLC | $31.63 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $23.77 | 2024 | Jublia |
| Almirall LLC | $19.87 | 2024 | Seysara |
| Dermavant Sciences, INC. | $16.26 | 2024 | Vtama |
| Incyte Corporation | $15.92 | 2024 | Opzelura |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $15.16 | 2021 | |
| Organon LLC | $15.15 | 2025 | Vtama |
| Regeneron Healthcare Solutions, INC. | $14.71 | 2024 | Libtayo |
| Arcutis Biotherapeutics, INC. | $13.49 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.